| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Protein kinase, cAMP-dependent, regulatory, type I, beta (PRKAR1B), transcript variant 4 from ORIGENE TECHNOLOGIES | LY431888 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type I, beta (PRKAR1B), transcript variant 5 from ORIGENE TECHNOLOGIES | LY431889 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type I, beta (PRKAR1B), transcript variant 6 from ORIGENE TECHNOLOGIES | LY431890 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type II, alpha (PRKAR2A) from ORIGENE TECHNOLOGIES | LY401337 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type II, beta (PRKAR2B) from ORIGENE TECHNOLOGIES | LY419138 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase C and casein kinase substrate in neurons 1 (PACSIN1) from ORIGENE TECHNOLOGIES | LY412198 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase C and casein kinase substrate in neurons 2 (PACSIN2) from ORIGENE TECHNOLOGIES | LY416115 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase C and casein kinase substrate in neurons 3 (PACSIN3) from ORIGENE TECHNOLOGIES | LY414084 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase C and casein kinase substrate in neurons 2 (PACSIN2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY433094 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase C, beta (PRKCB), transcript variant 1 from ORIGENE TECHNOLOGIES | LY403957 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase C, beta (PRKCB), transcript variant 2 from ORIGENE TECHNOLOGIES | LY419133 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase C, beta (PRKCB), transcript variant 1 from ORIGENE TECHNOLOGIES | LY431009 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase C, delta binding protein (PRKCDBP) from ORIGENE TECHNOLOGIES | LY403419 | 100 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cecum, normal from ORIGENE TECHNOLOGIES | CR562071 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cecum, normal from ORIGENE TECHNOLOGIES | CR562515 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix; Adenocarcinoma, metastatic, consistent with cervical primary from ORIGENE TECHNOLOGIES | CR561176 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix; Adenocarcinoma of cervix, endometrioid from ORIGENE TECHNOLOGIES | CR559855 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix; Adenocarcinoma of cervix, metastatic from ORIGENE TECHNOLOGIES | CR561219 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix; Carcinoma of cervix, adenosquamous from ORIGENE TECHNOLOGIES | CR560213 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIES | CR561343 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIES | CR561547 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIES | CR562330 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix; Carcinoma of cervix, squamous cell, large cell, non-keratinizing from ORIGENE TECHNOLOGIES | CR561268 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix; Carcinoma of cervix, squamous cell, large cell, non-keratinizing from ORIGENE TECHNOLOGIES | CR562939 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix; Carcinoma of cervix, squamous cell, large cell, non-keratinizing from ORIGENE TECHNOLOGIES | CR559345 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix; Carcinoma of cervix, squamous cell, metastatic from ORIGENE TECHNOLOGIES | CR559162 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix; Leiomyosarcoma from ORIGENE TECHNOLOGIES | CR563029 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix, normal from ORIGENE TECHNOLOGIES | CR559475 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix, normal from ORIGENE TECHNOLOGIES | CR559176 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix, normal from ORIGENE TECHNOLOGIES | CR559790 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix, normal from ORIGENE TECHNOLOGIES | CR560362 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix, normal from ORIGENE TECHNOLOGIES | CR559818 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix, normal from ORIGENE TECHNOLOGIES | CR560873 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix, normal from ORIGENE TECHNOLOGIES | CR561069 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix, normal from ORIGENE TECHNOLOGIES | CR561459 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix, normal from ORIGENE TECHNOLOGIES | CR561486 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix, normal from ORIGENE TECHNOLOGIES | CR561748 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix, normal from ORIGENE TECHNOLOGIES | CR561765 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix, normal from ORIGENE TECHNOLOGIES | CR562319 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix, normal from ORIGENE TECHNOLOGIES | CR562375 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix, normal from ORIGENE TECHNOLOGIES | CR562929 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cervix, normal from ORIGENE TECHNOLOGIES | CR563004 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Chest wall; Leiomyosarcoma, metastatic from ORIGENE TECHNOLOGIES | CR559359 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Adenocarcinoma, metastatic, consistent with colon primary from ORIGENE TECHNOLOGIES | CR562869 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Adenocarcinoma of colon from ORIGENE TECHNOLOGIES | CR559662 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Adenocarcinoma of colon from ORIGENE TECHNOLOGIES | CR559305 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Adenocarcinoma of colon from ORIGENE TECHNOLOGIES | CR559295 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Adenocarcinoma of colon from ORIGENE TECHNOLOGIES | CR559665 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Adenocarcinoma of colon from ORIGENE TECHNOLOGIES | CR560037 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Adenocarcinoma of colon from ORIGENE TECHNOLOGIES | CR560610 | 5 ug | ORIGENE TECHNOLOGIES |